Effects of intravitreal Bevacizumab (Avastin) monotherapy in central retinal vein occlusion in young subjects
Romanian Journal of Ophthalmology · 2024
DOI: 10.22336/rjo.2024.51 ↗Kurz gefasst
Fachartikel in der Zeitschrift Romanian Journal of Ophthalmology, 2024. Verfasst von Sarita Lobo und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Father Muller Medical College, Mangalore, Karnataka, India. Hauptthemen laut MEDLINE: Bevacizumab, Retinal Vein Occlusion, Intravitreal Injections, Angiogenesis Inhibitors. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, Father Muller Medical College, Mangalore, Karnataka, India.
- Department of Ophthalmology, Alluri Sitaramaraju Academy of Medical Sciences, Maikapuram, Eluri, Andhra Pradesh, India.
- Department of Neurosurgery, Father Muller Medical College, Mangalore, Karnataka, India.
Zitieren
APA
Lobo, S., Vivekanand, U., & Lobo, G. J. (2024). Effects of intravitreal Bevacizumab (Avastin) monotherapy in central retinal vein occlusion in young subjects. Romanian Journal of Ophthalmology. https://doi.org/10.22336/rjo.2024.51
Vancouver
Lobo S, Vivekanand U, Lobo GJ. Effects of intravitreal Bevacizumab (Avastin) monotherapy in central retinal vein occlusion in young subjects. Romanian Journal of Ophthalmology. 2024. doi:10.22336/rjo.2024.51
BibTeX
@article{Lobo2024,
author = {Lobo, Sarita and Vivekanand, Undrakonda and Lobo, Geover Joslen},
title = {Effects of intravitreal Bevacizumab (Avastin) monotherapy in central retinal vein occlusion in young subjects},
journal = {Romanian Journal of Ophthalmology},
year = {2024},
doi = {10.22336/rjo.2024.51}
}
EUVIMED